Back to Search Start Over

Effect of Aspirin on Activities of Daily Living Disability in Community-Dwelling Older Adults.

Authors :
Woods RL
Espinoza S
Thao LTP
Ernst ME
Ryan J
Wolfe R
Shah RC
Ward SA
Storey E
Nelson MR
Reid CM
Lockery JE
Orchard SG
Trevaks RE
Fitzgerald SM
Stocks NP
Williamson JD
McNeil JJ
Murray AM
Newman AB
Source :
The journals of gerontology. Series A, Biological sciences and medical sciences [J Gerontol A Biol Sci Med Sci] 2021 Oct 13; Vol. 76 (11), pp. 2007-2014.
Publication Year :
2021

Abstract

Background: Cerebrovascular events, dementia, and cancer can contribute to physical disability with activities of daily living (ADL). It is unclear whether low-dose aspirin reduces this burden in aging populations. In a secondary analysis, we now examine aspirin's effects on incident and persistent ADL disability within a primary prevention aspirin trial in community-dwelling older adults.<br />Methods: The ASPREE (ASPirin in Reducing Events in the Elderly) trial of daily 100 mg aspirin versus placebo recruited 19 114 healthy adults aged 70+ years (65+ years if U.S. minority) in Australia and the United States. Six basic ADLs were assessed every 6 months. Incident ADL disability was defined as inability or severe difficulty with ≥1 ADL; persistence was confirmed if the same ADL disability remained after 6 months. Proportional hazards modeling compared time to incident or persistent ADL disability for aspirin versus placebo; death without prior disability was a competing risk.<br />Results: Over a median of 4.7 years, incident ADL disability was similar in those receiving aspirin (776/9525) and placebo (787/9589) with walking, bathing, dressing, and transferring the most commonly reported. Only 24% of incident ADL disability progressed to persistent. Persistent ADL disability was lower in the aspirin group (4.3 vs 5.3 events/1000 py; hazard ratio [HR] = 0.81, 95% confidence interval [CI]: 0.66-1.00), with bathing and dressing the most common ADL disabilities in both groups. Following persistent ADL disability, there were more deaths in the aspirin group (24 vs 12).<br />Discussion: Low-dose aspirin in initially healthy older people did not reduce the risk of incident ADL disability, although there was evidence of reduced persistent ADL disability.<br /> (© The Author(s) 2020. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)

Details

Language :
English
ISSN :
1758-535X
Volume :
76
Issue :
11
Database :
MEDLINE
Journal :
The journals of gerontology. Series A, Biological sciences and medical sciences
Publication Type :
Academic Journal
Accession number :
33367621
Full Text :
https://doi.org/10.1093/gerona/glaa316